Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

CYCLOOXYGENASES 1 AND 2

Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,737 · see citing works

Cyclooxygenase in biology and disease

Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R., Simon, L. S., Putte, L., & Lipsky, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,606 · see citing works

Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2

Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,973 · see citing works

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,922 · see citing works

A second endogenous cannabinoid that modulates long-term potentiation

Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496 · see citing works

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310 · see citing works

Prostaglandin synthase 2

Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,200 · see citing works

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop‐Bailey, D., Croxtall, J. D., & Willoughby, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2046 · Cited by 1,035 · see citing works

Detection and Isolation of an Endoperoxide Intermediate in Prostaglandin Biosynthesis

Hámberg, M., & Samuelsson, B. O. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.899 · Cited by 644 · see citing works

Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.

Bleasdale, J. E., Thakur, N. R., Gremban, R. S., Bundy, G. L., Fitzpatrick, F. A., Smith, R. J., & Bunting, S. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22967-6 · Cited by 629 · see citing works

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

Luong, C., Miller, A. B., Barnett, J. W., Chow, J., Ramesha, C. S., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 620 · see citing works

Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis

Landino, L. M., Crews, B. C., Timmons, M. D., Morrow, J. D., & Marnett, L. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15069 · Cited by 423 · see citing works

A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors

Gierse, J. K., McDonald, J. J., Hauser, S. D., Rangwala, S. H., Koboldt, C. M., & Seibert, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15810 · Cited by 410 · see citing works

CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS

Felder, C. C., & Glass, M. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.179 · Cited by 410 · see citing works

Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2

Yu, M., Ives, D., & Ramesha, C. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21181 · Cited by 406 · see citing works

Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor

Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., & Waku, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.605 · Cited by 370 · see citing works

Transcriptional Activation of the Cyclooxygenase-2 Gene in Endotoxin-treated RAW 264.7 Macrophages

Wadleigh, D. J., Reddy, S. T., Kopp, E. B., Ghosh, S., & Herschman, H. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6259 · Cited by 340 · see citing works

Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor

Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2794 · Cited by 311 · see citing works

Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophages

Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296 · see citing works

Structural insights into the stereochemistry of the cyclooxygenase reaction

Kiefer, J. R., Pawlitz, J. L., Moreland, K. T., Stegeman, R. A., Hood, W. F., Gierse, J. K., Stevens, A. M., Goodwin, D. C., Rowlinson, S. W., Marnett, L. J., et al. (2000) · Nature · doi:10.1038/35011103 · Cited by 278 · see citing works

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells

Bisogno, T., Sepe, N., Melck, D. J., Maurelli, S., PETROCELLIS, L. D., & Marzo, V. D. (1997) · Biochemical Journal · doi:10.1042/bj3220671 · Cited by 273 · see citing works

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors

Kalgutkar, A. S. S., Crews, B. C., Rowlinson, S. W., Marnett, A. B., Kozak, K. R., Remmel, R. P., & Marnett, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.925 · Cited by 252 · see citing works

Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis

Shimokawa, T., Kulmacz, R. J., DeWitt, D. L., & Smith, W. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30468-4 · Cited by 229 · see citing works

Relative activities of rat and dog platelet phospholipase A2 and diglyceride lipase. Selective inhibition of diglyceride lipase by RHC 80267.

Sutherland, C. A., & Amin, D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45334-9 · Cited by 198 · see citing works

Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.

Jeon, Y. J., Yang, K. H., Pulaski, J. T., & Kaminski, N. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09237-5 · Cited by 190 · see citing works

Involvement of Arginine 120, Glutamate 524, and Tyrosine 355 in the Binding of Arachidonate and 2-Phenylpropionic Acid Inhibitors to the Cyclooxygenase Active Site of Ovine Prostaglandin Endoperoxide H Synthase-1

Bhattacharyya, D. K., Lecomte, M., Rieke, C. J., Garavito, R. M., & Smith, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2179 · Cited by 186 · see citing works

Phosphatidic Acid as the Biosynthetic Precursor of the Endocannabinoid 2‐Arachidonoylglycerol in Intact Mouse Neuroblastoma Cells Stimulated with Ionomycin

Bisogno, T., Melck, D. J., PETROCELLIS, L. D., & Marzo, V. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722113.x · Cited by 162 · see citing works

Oxidative metabolism of anandamide

BURSTEIN, S. H., Rossetti, R. G., Yagen, B., & Zurier, R. B. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00053-8 · Cited by 145 · see citing works

Prostaglandin G/H Synthase Isoenzyme 2 Expression in Fibroblasts - Regulation by Dexamethasone, Mitogens, and Oncogenes

Evett, G. E., Xie, W., Chipman, J. G., Robertson, D. L., & Simmons, D. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1496 · Cited by 133 · see citing works

Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.

Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., & Martin, B. R. (1999) · PubMed · Cited by 132 · see citing works

The Binding of Arachidonic Acid in the Cyclooxygenase Active Site of Mouse Prostaglandin Endoperoxide Synthase-2 (COX-2)

Rowlinson, S. W., Crews, B. C., Lanzo, C. A., & Marnett, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23305 · Cited by 128 · see citing works

Cannabimimetic Fatty Acid Derivatives: The Anandamide Family and Other 'Endocannabinoids'

Melck, D. J., Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., & Martin, B. R. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401141630 · Cited by 119 · see citing works

Covalent Modification of Cyclooxygenase-2 (COX-2) by 2-Acetoxyphenyl Alkyl Sulfides, a New Class of Selective COX-2 Inactivators

Kalgutkar, A. S. S., Kozak, K. R., Crews, B. C., Hochgesang, G. P., & Marnett, L. J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980303s · Cited by 117 · see citing works

Role of Val509 in Time-dependent Inhibition of Human Prostaglandin H Synthase-2 Cyclooxygenase Activity by Isoform-selective Agents

Guo, Q., Wang, L., Ruan, K., & Kulmacz, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19134 · Cited by 114 · see citing works

Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.

PINTO, J. C., Potié, F., Rice, K. C., Boring, D. L., Johnson, M. R., Evans, D. M., Wilken, G. H., Cantrell, C. H., & Howlett, A. C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09729-9 · Cited by 109 · see citing works

Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom.

Marnett, L. J., Siedlik, P. H., Ochs, R. C., Pagels, W. R., Das, M., Honn, K. V., Warnock, R., Tainer, B., & Eling, T. E. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15092-x · Cited by 100 · see citing works

The Dynamics of Prostaglandin H Synthases

So, O., Scarafia, L. E., Mak, A. Y., Callan, O., & Swinney, D. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5801 · Cited by 91 · see citing works

Spatial Requirements for 15-(R)-Hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic Acid Synthesis within the Cyclooxygenase Active Site of Murine COX-2

Rowlinson, S. W., Crews, B. C., Goodwin, D. C., Schneider, C. G., Gierse, J. K., & Marnett, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6586 · Cited by 87 · see citing works

The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs

Greig, G. M., Francis, D. A., Falgueyret, J., Ouellet, M., Percival, M. D., Roy, P. J., Bayly, C. I., Mancini, J. A., & O’Neill, G. P. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.829 · Cited by 86 · see citing works

[52] Preparation and proteolytic cleavage of apoprostaglandin endoperoxide synthase

Odenwaller, R., Chen, Y. P., & Marnett, L. J. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)87054-7 · Cited by 33 · see citing works

Biosynthesis of arachidonic acid metabolites in Limulus polyphemus amebocytes: analysis by liquid chromatography-electrospray ionization mass spectrometry

MacPherson, J. C., Pavlovich, J. G., & Jacobs, R. S. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00097-5 · Cited by 20 · see citing works

Nonenzymic reduction of prostaglandin H by lipoic acid

Marnett, L. J., & Bienkowski, M. J. (1977) · Biochemistry · doi:10.1021/bi00638a027 · Cited by 13 · see citing works

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A., Selley, D. E., Parsons, L. H., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 938 · see citing works

ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS

Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 779 · see citing works

Multiple Functions of Endocannabinoid Signaling in the Brain

Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630 · see citing works

Why there are two cyclooxygenase isozymes

Smith, W. L., & Langenbach, R. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13271 · Cited by 612 · see citing works

Cannabinoid receptors and their ligands

Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0341 · Cited by 558 · see citing works

Enzymatic pathways that regulate endocannabinoid signaling in the nervous system

Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529 · see citing works

Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice

Gao, Y., Vasilyev, D. V., Goncalves, M. B., Howell, F. V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.-Y., Strassle, B. W., Lu, P., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5693-09.2010 · Cited by 473 · see citing works

When does acute pain become chronic?

Voscopoulos, C., & Lema, M. (2010) · British Journal of Anaesthesia · doi:10.1093/bja/aeq323 · Cited by 473 · see citing works

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

Julien, B., Grenard, P., Teixeira-Clerc, F., Nhieu, J. T. V., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470 · see citing works

Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Hillard, C. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.130 · Cited by 449 · see citing works

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 438 · see citing works

Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides

Kozak, K. R., Crews, B. C., Morrow, J. D., Wang, L.-H., Ma, Y. H., Weinander, R., Jakobsson, P.-J., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206788200 · Cited by 368 · see citing works

The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

Marzo, V. D. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.010 · Cited by 367 · see citing works

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

SUGIURA, T., KISHIMOTO, S., OKA, S., & Gokoh, M. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.003 · Cited by 356 · see citing works

The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications

Lambert, D. M., & Fowler, C. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058183t · Cited by 350 · see citing works

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0356 · Cited by 346 · see citing works

Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism

Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336 · see citing works

Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways

Rouzer, C. A., & Marnett, L. J. (2011) · Chemical Reviews · doi:10.1021/cr2002799 · Cited by 301 · see citing works

Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes

Manzanares, J., Julian, M., & Carrascosa, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019527 · Cited by 287 · see citing works

Sensory and Signaling Mechanisms of Bradykinin, Eicosanoids, Platelet-Activating Factor, and Nitric Oxide in Peripheral Nociceptors

Pethö, G., & Reeh, P. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00048.2010 · Cited by 288 · see citing works

Cannabinoid receptors and endocannabinoids: Evidence for new players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 275 · see citing works

Endocannabinoid signaling in microglial cells

Stella, N. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.037 · Cited by 271 · see citing works

Mechanism of Free Radical Oxygenation of Polyunsaturated Fatty Acids by Cyclooxygenases

Rouzer, C. A., & Marnett, L. J. (2003) · Chemical Reviews · doi:10.1021/cr000068x · Cited by 266 · see citing works

Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the CNS

Murataeva, N., Straiker, A. J., & Mackie, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12411 · Cited by 253 · see citing works

COX-2-derived endocannabinoid metabolites as novel inflammatory mediators

Alhouayek, M., & Muccioli, G. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.001 · Cited by 253 · see citing works

An introduction to the endocannabinoid system: from the early to the latest concepts

PETROCELLIS, L. D., & Marzo, V. D. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.013 · Cited by 249 · see citing works

Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone

Orlando, B. J., & Malkowski, M. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725713 · Cited by 261 · see citing works

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor

Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705304 · Cited by 244 · see citing works

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites

Turcotte, C., Chouinard, F., Lefebvre, J. S., & Flamand, N. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0115-021r · Cited by 249 · see citing works

Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus

Kim, J., & Alger, B. E. (2004) · Nature Neuroscience · doi:10.1038/nn1262 · Cited by 238 · see citing works

Cyclooxygenase-2 Biology

Clària, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454054 · Cited by 238 · see citing works

The endocannabinoid system as a target for novel anxiolytic drugs

Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233 · see citing works

Electrospray ionization and tandem mass spectrometry of eicosanoids

Murphy, R. C., Barkley, R. M., Berry, K. A. Z., Hankin, J. A., Harrison, K. A., Johnson, C. A., Krank, J., McAnoy, A. M., Uhlson, C. L., & Zarini, S. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.042 · Cited by 231 · see citing works

2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain

Baggelaar, M. P., Maccarrone, M., & van der Stelt, M. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.05.002 · Cited by 224 · see citing works

Effects of cannabinoids on LPS‐stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids

Chang, Y., Lee, S. T., & Lin, W. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1103 · Cited by 219 · see citing works

Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy

Romano, M., & Clària, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0053rev · Cited by 222 · see citing works

Cannabinoid signaling in glial cells

Stella, N. (2004) · Glia · doi:10.1002/glia.20084 · Cited by 218 · see citing works

Cyclooxygenase enzymes: catalysis and inhibition

Kurumbail, R. G. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(01)00277-9 · Cited by 212 · see citing works

Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs

Rouzer, C. A., & Marnett, L. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00215 · Cited by 206 · see citing works

Cyclooxygenase-2 in synaptic signaling

Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195 · see citing works

Paracetamol – An old drug with new mechanisms of action

Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190 · see citing works

Cannabis, cannabinoids and reproduction

Park, B., McPartland, J. M., & Glass, M. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.007 · Cited by 189 · see citing works

15-Lipoxygenase Metabolism of 2-Arachidonylglycerol

Kozak, K. R., Gupta, R. A., Moody, J. S., Ji, C., Boeglin, W. E., DuBois, R. N., BRASH, A. R., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201084200 · Cited by 187 · see citing works

Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus

Hashimotodani, Y., Ohno‐Shosaku, T., & Kano, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4159-06.2007 · Cited by 186 · see citing works

(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2

Duggan, K. C., Hermanson, D. J., Musee, J., Prusakiewicz, J. J., Scheib, J. L., Carter, B. D., Banerjee, S., Oates, J. A., & Marnett, L. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.663 · Cited by 184 · see citing works

Eicosanoid signalling pathways in the heart

Jenkins, C. M., Cedars, A. M., & Gross, R. W. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn346 · Cited by 182 · see citing works

The Biosynthesis of Enzymatically Oxidized Lipids

Hajeyah, A. A., Griffiths, W. J., Wang, Y., Finch, A. J., & O’Donnell, V. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.591819 · Cited by 192 · see citing works

Endocannabinoids in the retina: From marijuana to neuroprotection

Yazulla, S. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.07.002 · Cited by 178 · see citing works

Cannabinoid Mechanisms of Pain Suppression

Walker, J. M., & Hohmann, A. G. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 177 · see citing works

The enzymology of prostaglandin endoperoxide H synthases-1 and -2

Smith, W. L., & Song, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00025-4 · Cited by 173 · see citing works

Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells

Muccioli, G. G., Xu, C., Odah, E., Cudaback, E., Cisneros, J. A., Lambert, D. M., López-Rodríguez, M. L., Bajjalieh, S., & Stella, N. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4830-06.2007 · Cited by 172 · see citing works

Oxidative metabolism of endocannabinoids

Kozak, K. R., & Marnett, L. J. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0359 · Cited by 170 · see citing works

Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling

Pan, B., Wang, W., Long, J. Z., Sun, D., Hillard, C. J., Cravatt, B. F., & Liu, Q.-S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158162 · Cited by 165 · see citing works

Structural Basis of Fatty Acid Substrate Binding to Cyclooxygenase-2

Vecchio, A. J., Simmons, D. M., & Malkowski, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119867 · Cited by 165 · see citing works

LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis

Reed, A., Ichu, T.-A., Milosevich, N., Melillo, B. N., Schafroth, M. A., Otsuka, Y., Scampavia, L. D., Spicer, T., & Cravatt, B. F. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00317 · Cited by 167 · see citing works

Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB 1 receptor‐dependent G‐protein activation in rat cerebellar membranes

Savinainen, J. R., Järvinen, T., Laine, K., & Laitinen, J. T. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704297 · Cited by 159 · see citing works

Characterization of the Sulfhydryl-Sensitive Site in the Enzyme Responsible for Hydrolysis of 2- Arachidonoyl-Glycerol in Rat Cerebellar Membranes

Saario, S. M., Salo‐Ahen, O. M. H., Nevalainen, T., Poso, A., Laitinen, J. T., Järvinen, T., & Niemi, R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.013 · Cited by 158 · see citing works

CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids

McAllister, S. D., & Glass, M. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0344 · Cited by 158 · see citing works

Monoacylglycerols Activate TRPV1 – A Link between Phospholipase C and TRPV1

Zygmunt, P. M., Ermund, A., Movahed, P., Andersson, D. A., Simonsen, C., Jönsson, B., Blomgren, A., Birnir, B., Bevan, S., Eschalier, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081618 · Cited by 157 · see citing works

Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa

Ruhaak, L. R., Felth, J., Karlsson, P. C., Rafter, J. J., Verpoorte, R., & Bohlin, L. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.774 · Cited by 154 · see citing works

Prostaglandin E ₂ glycerol ester, an endogenous COX‐2 metabolite of 2‐arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity

Hu, S. S., Bradshaw, H. B., Chen, J. S., Tan, B., & Walker, J. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.33 · Cited by 151 · see citing works

Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke

Ye, Y. N. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi012 · Cited by 150 · see citing works

Cannabinoid Receptors and Endocannabinoids: Evidence for New Players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1208/aapsj080234 · Cited by 149 · see citing works

Alterations of Endocannabinoid Signaling, Synaptic Plasticity, Learning, and Memory in Monoacylglycerol Lipase Knock-out Mice

Pan, B., Wang, W., Zhong, P., Blankman, J. L., Cravatt, B. F., & Liu, Q.-S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2075-11.2011 · Cited by 147 · see citing works

Endogenous cannabinoids revisited: A biochemistry perspective

Fonseca, B. M., Costa, M. A., Almada, M., Correia‐da‐Silva, G., & Teixeira, N. A. A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.02.002 · Cited by 147 · see citing works

Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways

Serhan, C. N., & Oliw, E. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13375 · Cited by 146 · see citing works

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

Jhaveri, M. D., Richardson, D. S., & Chapman, V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707433 · Cited by 145 · see citing works

Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024)

Woodward, D. F., Krauss, A. H. ‐., Chen, J., Liang, Y., Li, C., Protzman, C. E., Bogardus, A. M., Chen, R., Kedzie, K. M., Krauss, H. A., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047837 · Cited by 143 · see citing works

Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol

Szabó, B., Urbanski, M. J., Bisogno, T., Marzo, V. D., Mendiguren, A., Baer, W. U., & Freiman, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119362 · Cited by 141 · see citing works

Phospholipid-esterified Eicosanoids Are Generated in Agonist-activated Human Platelets and Enhance Tissue Factor-dependent Thrombin Generation

Thomas, C. P., Morgan, L. T., Maskrey, B. H., Murphy, R. C., Kühn, H., Hazen, S. L., Goodall, A. H., Hamali, H. A., Collins, P. W., & O’Donnell, V. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078428 · Cited by 140 · see citing works

Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid

Prusakiewicz, J. J., Duggan, K. C., Rouzer, C. A., & Marnett, L. J. (2009) · Biochemistry · doi:10.1021/bi900999z · Cited by 139 · see citing works

Metabolism of Prostaglandin Glycerol Esters and Prostaglandin Ethanolamides in Vitro and in Vivo

Kozak, K. R., Crews, B. C., Ray, J. L., Tai, H., Morrow, J. D., & Marnett, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105854200 · Cited by 139 · see citing works

Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids

Astarita, G., Kendall, A. C., Dennis, E. A., & Nicolaou, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.012 · Cited by 138 · see citing works

Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation

Wang, M., Hill, M. N., Zhang, L., Gorzalka, B. B., Hillard, C. J., & Alger, B. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111409606 · Cited by 137 · see citing works

The Structure of Mammalian Cyclooxygenases

Garavito, R. M., & Mulichak, A. M. (2003) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.32.110601.141906 · Cited by 137 · see citing works

Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation

Zhang, J., & Chen, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800524200 · Cited by 135 · see citing works

Endocannabinoid system: Role in depression, reward and pain control (Review)

Huang, W., Chen, W., & Zhang, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5585 · Cited by 135 · see citing works

The complications of promiscuity: endocannabinoid action and metabolism

Alexander, S. P. H., & Kendall, D. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707456 · Cited by 133 · see citing works

More surprises lying ahead. The endocannabinoids keep us guessing

Piomelli, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.026 · Cited by 128 · see citing works

New insights into COX-2 biology and inhibition

Patrignani, P., Tacconelli, S., Sciulli, M. G., & Capone, M. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.024 · Cited by 128 · see citing works

Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors

van Egmond, N., Straub, V. M., & van der Stelt, M. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-112741 · Cited by 129 · see citing works

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

Hermanson, D. J., Hartley, N. D., Gamble-George, J., Brown, N., Shonesy, B. C., Kingsley, P. J., Colbran, R. J., Reese, J., Marnett, L. J., & Patel, S. (2013) · Nature Neuroscience · doi:10.1038/nn.3480 · Cited by 126 · see citing works

Endocannabinoid System Modulates Relapse to Methamphetamine Seeking: Possible Mediation by the Arachidonic Acid Cascade

Anggadiredja, K., Nakamichi, M., Hiranita, T., Tanaka, H., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300454 · Cited by 125 · see citing works

COX-2 as a multifunctional neuronal modulator

Bazan, N. G. (2001) · Nature Medicine · doi:10.1038/86477 · Cited by 125 · see citing works

The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways

Smith, W. L., & Murphy, R. C. (2008) · Elsevier eBooks · doi:10.1016/b978-044453219-0.50014-3 · Cited by 123 · see citing works

Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation

Hermanson, D. J., Gamble‐George, J., Marnett, L. J., & Patel, S. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.006 · Cited by 121 · see citing works

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 121 · see citing works

Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants

Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 118 · see citing works

Modulation of the serotonin system by endocannabinoid signaling

Haj‐Dahmane, S., & Shen, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.016 · Cited by 117 · see citing works

Endocannabinoids and neurodegenerative diseases

Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 117 · see citing works

Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids

Rouzer, C. A., & Marnett, L. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800005200 · Cited by 116 · see citing works

Cyclooxygenase-2-specific Inhibitor Improves Functional Outcomes, Provides Neuroprotection, and Reduces Inflammation in a Rat Model of Traumatic Brain Injury

Gopez, J., Yue, H., Vasudevan, R., Malik, A. S., Fogelsanger, L. N., Lewis, S. A., Panikashvili, D., Shohami, E., Jansen, S. A., Narayan, R. K., et al. (2005) · Neurosurgery · doi:10.1227/01.neu.0000154060.14900.8f · Cited by 113 · see citing works

The glyceryl ester of prostaglandin E 2 mobilizes calcium and activates signal transduction in RAW264.7 cells

Nirodi, C. S., Crews, B. C., Kozak, K. R., Morrow, J. D., & Marnett, L. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303950101 · Cited by 113 · see citing works

Postictal hypoperfusion/hypoxia provides the foundation for a unified theory of seizure‐induced brain abnormalities and behavioral dysfunction

Farrell, J. S., Colangeli, R., Wolff, M. D., Wall, A. K., Phillips, T. J., George, A. G., Federico, P., & Teskey, G. C. (2017) · Epilepsia · doi:10.1111/epi.13827 · Cited by 112 · see citing works

A review of pharmacological and pharmacokinetic properties of Forsythiaside A

Gong, L., Wang, C., Zhou, H., Ma, C., Zhang, Y., Peng, C. Y., & Li, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105690 · Cited by 110 · see citing works

Cannabinoids and the Brain

Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110 · see citing works

The Role of Brain Cyclooxygenase-2 (Cox-2) Beyond Neuroinflammation: Neuronal Homeostasis in Memory and Anxiety

Ramos, D. L., & Ballaz, S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02087-x · Cited by 108 · see citing works

Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids

Hanuš, L. O. (2008) · Medicinal Research Reviews · doi:10.1002/med.20135 · Cited by 110 · see citing works

Lipidomic analysis of endocannabinoid metabolism in biological samples

Astarita, G., & Piomelli, D. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.01.008 · Cited by 107 · see citing works

Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain

Strauss, K. I. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.09.011 · Cited by 105 · see citing works

Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids

Rouzer, C. A., & Marnett, L. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800005200 · Cited by 116 · see citing works

Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain

Morgan, A., Kingsley, P. J., Mitchener, M. M., Altemus, M., Patrick, T. A., Gaulden, A. D., Marnett, L. J., & Patel, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00499 · Cited by 38 · see citing works

Assay of Endocannabinoid Oxidation by Cyclooxygenase-2

Kudalkar, S. N., Kingsley, P. J., & Marnett, L. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3539-0_21 · Cited by 9 · see citing works

Endocannabinoid oxygenation by prostaglandin H synthase-2: Chemistry and biology

Rouzer, C. A., & Marnett, L. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110870 · Cited by 1 · see citing works

Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol

Kozak, K. R., Prusakiewicz, J. J., Rowlinson, S. W., Schneider, C. G., & Marnett, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104467200 · Cited by 66 · see citing works